Skip to main content
. 2024 Feb 29;31:100704. doi: 10.1016/j.lana.2024.100704

Table 1.

Characteristics of individuals conducting lay anal examinations and concordance with clinician examinations in Chicago, Illinois and Houston, Texas, USA 2020–2022.

Enrolled Concordance (95% CI)
Overall 714/714 (100.0%) 0.73 (0.70–0.76)
Age, years 40 (32–54)
Age, years
 25–34 252/714 (35.3%) 0.79 (0.74–0.84)
 35–44 161/714 (22.6%) 0.71 (0.64–0.78)
 45–54 145/714 (20.3%) 0.72 (0.65–0.80)
 55–81 156/714 (21.9%) 0.67 (0.59–0.74)
Waist circumference, cm
 ≤102 473/708 (66.8%) 0.75 (0.72–0.79)
 >102 235/708 (33.2%) 0.68 (0.62–0.74)
Sex at birth
 Male 703/714 (98.5%) 0.73 (0.70–0.77)
 Female 11/714 (1.5%) 0.64 (0.35–0.92)
Gender identity
 Man 671/713 (94.1%) 0.72 (0.69–0.76)
 Non-binary 18/713 (2.5%) 0.89 (0.74–1.00)
 Transgender woman 11/713 (1.5%) 0.82 (0.59–1.00)
 Transgender man 9/713 (1.3%) 0.78 (0.51–1.00)
 Woman or other 4/713 (0.6%) 0.75 (0.33–1.00)
Race/ethnicity
 White, non-Hispanic 334/710 (47.0%) 0.72 (0.67–0.76)
 Black, non-Hispanic 166/710 (23.4%) 0.80 (0.73–0.86)
 Hispanic 163/710 (23.0%) 0.69 (0.62–0.76)
 Asian, non-Hispanic 32/710 (4.5%) 0.81 (0.68–0.95)
 Other, non-Hispanica 15/710 (2.1%) 0.67 (0.43–0.91)
Sexual orientation
 Gay 601/713 (84.3%) 0.71 (0.68–0.75)
 Bisexual 67/713 (9.4%) 0.82 (0.73–0.91)
 Queer 35/713 (4.9%) 0.80 (0.67–0.93)
 Heterosexual, lesbian, I don’t know or other 10/713 (1.4%) 0.90 (0.71–1.00)
HIV status, self-report
 Negative 444/703 (63.2%) 0.75 (0.71–0.79)
 Positive 259/703 (36.8%) 0.70 (0.64–0.75)
Dexterity-related medical conditionb
 No 465/692 (67.2%) 0.75 (0.71–0.79)
 Yes 227/692 (32.8%) 0.68 (0.62–0.74)
Lay anal examination type
 Anal self-examination 658/714 (92.2%) 0.73 (0.70–0.76)
 Anal companion examination 56/714 (7.8%) 0.73 (0.62–0.85)
Trainer type
 Clinician 86/714 (12.0%) 0.85 (0.77–0.92)
 Non-clinician 628/714 (88.0%) 0.72 (0.68–0.75)
Clinician type
 Medical doctor 301/714 (42.2%) 0.78 (0.74–0.83)
 Advanced practice provider 413/714 (57.8%) 0.69 (0.65–0.74)
City
 Chicago 370/714 (51.8%) 0.76 (0.72–0.80)
 Houston 344/714 (48.2%) 0.70 (0.65–0.75)
Recruitment source
 Social media 304/711 (42.8%) 0.75 (0.70–0.80)
 Clinics 169/711 (23.8%) 0.70 (0.62–0.76)
 Friends 128/711 (18.0%) 0.73 (0.66–0.81)
 Flyers/advertisement 99/711 (13.9%) 0.74 (0.65–0.82)
 Other 11/711 (1.6%) 0.82 (0.59–1.00)
Lay anal examination results
 True negative 376/714 (52.7%) n/a
 True positive 146/714 (20.5%) n/a
 False negative 99/714 (13.9%) n/a
 False positive 93/714 (13.0%) n/a
Preferred anal sex position
 Insertive 163/693 (23.5%) 0.73 (0.66–0.80)
 Versatile 281/693 (40.6%) 0.74 (0.69–0.79)
 Receptive 245/693 (35.4%) 0.71 (0.65–0.76)
 Never had anal sex 4/693 (0.6%) 1.00 n/a
Difficulty with ASE/ACE
 Easy or very easy 640/708 (90.4%) 0.74 (0.71–0.77)
 Hard or very hard 68/708 (9.6%) 0.62 (0.50–0.73)
Pain with ASE/ACE
 None 681/710 (95.9%) 0.73 (0.69–0.76)
 A little 23/710 (3.2%) 0.78 (0.61–0.95)
 A lot 2/710 (0.3%) 1.00 n/a
 I don’t know 4/710 (0.6%) 1.00 n/a
Ever checked anus for disease
 No or I don’t know 385/713 (54.0%) 0.71 (0.67–0.76)
 Yes 328/713 (46.0%) 0.75 (0.70–0.80)
Worry about getting anal cancer
 None 421/710 (59.3%) 0.74 (0.70–0.78)
 A little 204/710 (28.7%) 0.70 (0.64–0.76)
 Some 68/710 (9.6%) 0.82 (0.73–0.91)
 Quite a lot 17/710 (2.4%) 0.47 (0.23–0.71)
Plans to do ASE/ACE in the future
 Strongly agree 508/709 (71.7%) 0.74 (0.70–0.78)
 Agree 184/709 (26.0%) 0.70 (0.63–0.77)
 Disagree 3/709 (0.4%) 1.00 n/a
 Strongly disagree 2/709 (0.3%) 0.00 n/a
 I don’t know 12/709 (1.7%) 0.77 (0.54–1.00)
Would see a doctor for a persistent anal problem
 Strongly agree 481/711 (67.7%) 0.74 (0.69–0.77)
 Agree 183/711 (25.7%) 0.75 (0.69–0.82)
 Disagree 12/711 (1.7%) 0.67 (0.40–0.93)
 Strongly disagree 3/711 (0.4%) 0.33 (0.00–0.87)
 I don’t know 32/711 (4.5%) 0.59 (0.42–0.76)
Preference for ASE/ACE or doctor-provided exam
 ASE or ACE 244/705 (34.6%) 0.75 (0.70–0.80)
 Doctor-provided exam 461/705 (65.4%) 0.72 (0.68–0.76)
COVID-19 pandemic-associated enrolment datec
 Prior to trial suspension 20/714 (2.8%) 0.70 (0.46–0.88)
 After trial resumed 694/714 (97.2%) 0.73 (0.70–0.77)

Note. Data are n (%) or median (interquartile range).

ASE/ACE, anal self-examination, or anal companion examination; n/a, not applicable.

a

Other includes Native American or Alaskan Native, Hawaiian or Pacific Islander, other, and I don’t know.

b

Conditions were arthritis, carpal tunnel syndrome, cerebral palsy, diabetes, fibromyalgia, chronic lower back pain, motor neuron diseases, multiple sclerosis, obesity, spina bifida, spinal cord injury, stroke, and other (neuropathy, lower back nerve compression, tremors in hand, McArdle disease, autism, scoliosis, knee pain, scapular dyskinesis, transverse myelitis, osteoporosis, thoracic outlet syndrome, cervicalgia, causalgia and herniated disc).

c

Study enrollment was suspended due to COVID-19 pandemic stay-at-home orders on March 14, 2020, and then resumed on July 30, 2020, in Chicago and October 1, 2020, in Houston.